Barile G
Biochem Biophys Rep. 2024; 38:101657.
PMID: 38371315
PMC: 10869749.
DOI: 10.1016/j.bbrep.2024.101657.
Santos-Lopez J, de la Paz K, Fernandez F, Vega M
Front Immunol. 2023; 14:1239146.
PMID: 37753090
PMC: 10518620.
DOI: 10.3389/fimmu.2023.1239146.
Xia W, Chen H, Feng Y, Shi N, Huang Z, Feng Q
Front Immunol. 2022; 12:789604.
PMID: 35111158
PMC: 8801525.
DOI: 10.3389/fimmu.2021.789604.
Soldan S, Su C, Lamontagne R, Grams N, Lu F, Zhang Y
PLoS Pathog. 2021; 17(6):e1009618.
PMID: 34106998
PMC: 8216538.
DOI: 10.1371/journal.ppat.1009618.
Annamalai B, Parsons N, Nicholson C, Joseph K, Coughlin B, Yang X
Exp Eye Res. 2021; 207:108583.
PMID: 33878326
PMC: 8504679.
DOI: 10.1016/j.exer.2021.108583.
Pathogenesis of Human Gammaherpesviruses: Recent Advances.
Weed D, Damania B
Curr Clin Microbiol Rep. 2020; 6(3):166-174.
PMID: 33134035
PMC: 7597832.
DOI: 10.1007/s40588-019-00127-2.
CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.
Smith N, Coleman C, Gewurz B, Rochford R
J Virol. 2020; 94(11).
PMID: 32238579
PMC: 7269432.
DOI: 10.1128/JVI.00428-20.
Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.
Zhao B, Zhang X, Krummenacher C, Song S, Gao L, Zhang H
Front Immunol. 2018; 9:932.
PMID: 29765376
PMC: 5938345.
DOI: 10.3389/fimmu.2018.00932.
Non-Invasive whole-body detection of complement activation using radionuclide imaging in a mouse model of myocardial ischaemia-reperfusion injury.
Sharif-Paghaleh E, Yap M, Puhl S, Badar A, Torres J, Chuamsaamarkkee K
Sci Rep. 2017; 7(1):16090.
PMID: 29170426
PMC: 5700950.
DOI: 10.1038/s41598-017-16387-1.
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
Atkinson C, Qiao F, Yang X, Zhu P, Reaves N, Kulik L
Circulation. 2015; 131(13):1171-80.
PMID: 25825397
PMC: 4382916.
DOI: 10.1161/CIRCULATIONAHA.114.010482.
Regulation of humoral immunity by complement.
Carroll M, Isenman D
Immunity. 2012; 37(2):199-207.
PMID: 22921118
PMC: 5784422.
DOI: 10.1016/j.immuni.2012.08.002.
Recombinant complement receptor 2 radiolabeled with [99mTc(CO)3]+: a potential new radiopharmaceutical for imaging activated complement.
Badar A, DeFreitas S, McDonnell J, Yahya N, Thakor D, Razavi R
PLoS One. 2011; 6(4):e18275.
PMID: 21494666
PMC: 3071809.
DOI: 10.1371/journal.pone.0018275.
Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.
Kovacs J, Hannan J, Eisenmesser E, Holers V
J Biol Chem. 2010; 285(35):27251-27258.
PMID: 20558730
PMC: 2930724.
DOI: 10.1074/jbc.M110.106617.
Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.
Busse C, Feederle R, Schnolzer M, Behrends U, Mautner J, Delecluse H
J Virol. 2009; 84(2):1139-47.
PMID: 19889766
PMC: 2798361.
DOI: 10.1128/JVI.01953-09.
Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.
Jiang R, Gu X, Nathan C, Hutt-Fletcher L
J Oral Pathol Med. 2008; 37(10):626-33.
PMID: 18710421
PMC: 2584167.
DOI: 10.1111/j.1600-0714.2008.00681.x.
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.
Song H, He C, Knaak C, Guthridge J, Holers V, Tomlinson S
J Clin Invest. 2003; 111(12):1875-85.
PMID: 12813023
PMC: 161422.
DOI: 10.1172/JCI17348.
Viral mimicry of the complement system.
Bernet J, Mullick J, Singh A, Sahu A
J Biosci. 2003; 28(3):249-64.
PMID: 12734404
PMC: 7090525.
DOI: 10.1007/BF02970145.
Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
Tang A, Kopeikova P, Kopeckeva J
Pharm Res. 2003; 20(3):360-7.
PMID: 12669954
DOI: 10.1023/a:1022639701388.
The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.
Prota A, Sage D, Stehle T, Fingeroth J
Proc Natl Acad Sci U S A. 2002; 99(16):10641-6.
PMID: 12122212
PMC: 124999.
DOI: 10.1073/pnas.162360499.
Origin and properties of soluble CD21 (CR2) in human blood.
LING N, Hardie D, JOHNSON G, MacLennan I
Clin Exp Immunol. 1998; 113(3):360-6.
PMID: 9737663
PMC: 1905057.
DOI: 10.1046/j.1365-2249.1998.00668.x.